Clinical Trial Update: Stratification and Treatment in Early Psychosis Study - PROMOTE [Phase 3]

View source ↗

Summary

Phase 3 PROMOTE trial in individuals at clinical high risk for psychosis; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia Spectrum and Other Psychotic Disorders

Snippet

Sponsor: University of Oxford | Conditions: Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis | Phase 3 | Status: NOT_YET_RECRUITING